STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 880 participants.

Also called NCT06901466

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 880 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06901466
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06901466. Randomized; no masking; primary purpose treatment. Start 2025-06-13 (actual); primary completion 2027-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
Acronym
STAR-TEER Ⅰ
Condition
Mitral Regurgitation
Intervention (Drug)
Experimental: Rivaroxaban monotherapy
Intervention (Drug)
Active Comparator: Rivaroxaban+Clopidogrel
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)

Record details

Record id
cardio:ct-nct06901466
Content hash
93393dac5025710dbca404124ea5d218ebb22d96d6599e245486e0895961a6e4